DE69132407D1 - Aerosol arzneiformulierungen - Google Patents

Aerosol arzneiformulierungen

Info

Publication number
DE69132407D1
DE69132407D1 DE69132407T DE69132407T DE69132407D1 DE 69132407 D1 DE69132407 D1 DE 69132407D1 DE 69132407 T DE69132407 T DE 69132407T DE 69132407 T DE69132407 T DE 69132407T DE 69132407 D1 DE69132407 D1 DE 69132407D1
Authority
DE
Germany
Prior art keywords
medical formulations
aerosol medical
aerosol
formulations
tetrafluoroethane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69132407T
Other languages
English (en)
Other versions
DE69132407T2 (de
Inventor
A Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/649,405 external-priority patent/US5126123A/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of DE69132407D1 publication Critical patent/DE69132407D1/de
Application granted granted Critical
Publication of DE69132407T2 publication Critical patent/DE69132407T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69132407T 1990-06-28 1991-06-27 Aerosol arzneiformulierungen Expired - Lifetime DE69132407T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54543790A 1990-06-28 1990-06-28
US07/649,405 US5126123A (en) 1990-06-28 1991-02-01 Aerosol drug formulations
PCT/US1991/004715 WO1992000107A1 (en) 1990-06-28 1991-06-27 Aerosol drug formulations

Publications (2)

Publication Number Publication Date
DE69132407D1 true DE69132407D1 (de) 2000-10-12
DE69132407T2 DE69132407T2 (de) 2001-04-05

Family

ID=27067939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132407T Expired - Lifetime DE69132407T2 (de) 1990-06-28 1991-06-27 Aerosol arzneiformulierungen

Country Status (13)

Country Link
EP (1) EP0536250B1 (de)
JP (1) JP3056784B2 (de)
AT (1) ATE196076T1 (de)
AU (1) AU649702B2 (de)
CA (1) CA2083821A1 (de)
DE (1) DE69132407T2 (de)
ES (1) ES2151476T3 (de)
GB (1) GB2263064B (de)
IE (1) IE912246A1 (de)
IL (1) IL98639A0 (de)
NZ (1) NZ238749A (de)
PT (1) PT98105B (de)
WO (1) WO1992000107A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
JPH06508149A (ja) 1991-06-10 1994-09-14 シェリング・コーポレーション クロロフルオロカーボン不含エーロゾル製剤
GB9202522D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
CA2421976C (en) 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69432224T2 (de) * 1993-12-02 2003-12-04 Abbott Lab Aerosole als darreichungsform mit cfc-freiem treibmittel
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
PL368805A1 (en) * 2001-08-03 2005-04-04 Glaxo Group Limited Surfactant compounds and uses thereof
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
JP5087539B2 (ja) 2005-05-18 2012-12-05 ネクター セラピューティックス 気管支内治療のためのバルブ、デバイス、および方法
CA2622193A1 (en) 2005-09-29 2007-04-12 Nektar Therapeutics Antibiotic formulations, unit doses, kits, and methods
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
AU2008214205B2 (en) 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
EP3806939B1 (de) * 2018-06-13 2024-04-10 Puff-Ah Pty Ltd Vorrichtung zur verwendung bei der verabreichung von atemwegsmedikamenten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
EP0526481B1 (de) * 1990-03-23 1995-04-26 Minnesota Mining And Manufacturing Company Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe
FR2660297B1 (fr) * 1990-03-30 1992-06-12 Coflexip Dispositif de suspension et dispositif de liaison comportant un tel dispositif de suspension.
EP0536204B1 (de) * 1990-06-27 1994-04-06 Minnesota Mining And Manufacturing Company Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe

Also Published As

Publication number Publication date
NZ238749A (en) 1993-07-27
ATE196076T1 (de) 2000-09-15
AU649702B2 (en) 1994-06-02
EP0536250B1 (de) 2000-09-06
AU8213591A (en) 1992-01-23
GB2263064A (en) 1993-07-14
ES2151476T3 (es) 2001-01-01
IE912246A1 (en) 1992-01-01
GB9223891D0 (en) 1993-04-21
CA2083821A1 (en) 1991-12-29
JPH05507935A (ja) 1993-11-11
IL98639A0 (en) 1992-07-15
PT98105B (pt) 1998-11-30
EP0536250A1 (de) 1993-04-14
JP3056784B2 (ja) 2000-06-26
DE69132407T2 (de) 2001-04-05
GB2263064B (en) 1994-09-14
EP0536250A4 (en) 1993-06-16
PT98105A (pt) 1993-08-31
WO1992000107A1 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
DE69132407T2 (de) Aerosol arzneiformulierungen
EP0995434A3 (de) Medizinische Aerosolformulierungen
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
NZ238739A (en) Aerosol formulations comprising a powdered drug, a hydrofluorocarbon propellant and a perfluoroalkylsulphonamidoalkylphosphate surface-active agent
IL77467A (en) Drug-containing aerosol formulations comprising chlorofluorocarbon propellent
PT918507E (pt) Formulacoes em aerossol
MY131733A (en) Aerosol drug formulations
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
EP0636362A3 (de) Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe.
DE69021387T3 (de) Medizinische aerosolformulierungen.
WO1995017156A3 (en) Ethanol substitutes
NO913035L (no) (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
DK0550031T3 (da) Medicinsk aerosolformulering
KR910700058A (ko) 항-hiv제
ATE113829T1 (de) Pharmazeutische zusammensetzung.
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
DE60017450D1 (de) Pharmazeutische formulierungen enthaltend salmeterol
WO1991013606A3 (de) Verwendung von 3,7-dimethyloctan-1-ol in kosmetischen und dermatologischen präparaten
ES1015889Y (es) Mascarilla para uso medico-quirurgico.
GB2162746A (en) Antiacidotic medicinal agent
IT9022315A1 (it) Composti ad attivita' antiradicalica, procedimento per la loro prepara zione e loro impieghi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition